Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Gross Profit 2017–2025
Adaptive Biotechnologies Corporation annual/quarterly gross profit history and growth rate from 2017 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Adaptive Biotechnologies Corporation gross profit for the quarter ending March 31, 2026 was 52.2 M, a 47.10% increase year-over-year.
- Adaptive Biotechnologies Corporation gross profit for the twelve months ending March 31, 2026 was 204.3 M, a 112.76% increase year-over-year.
- Adaptive Biotechnologies Corporation annual gross profit for 2025 was 205.6 M, a 92.39% increase from 2024.
- Adaptive Biotechnologies Corporation annual gross profit for 2024 was 106.9 M, a 12.83% increase from 2023.
- Adaptive Biotechnologies Corporation annual gross profit for 2023 was 94.7 M, a 25.65% decrease from 2022.
- Adaptive Biotechnologies Corporation annual gross profit for 2022 was 127.4 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adaptive Biotechnologies Corporation Gross Profit — FAQ
Adaptive Biotechnologies Corporation (ADPT) gross profit over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Adaptive Biotechnologies Corporation's gross profit?
Adaptive Biotechnologies Corporation (ADPT) reported gross profit of $206M for fiscal 2025.
Where can I see ADPT's gross profit history?
The chart and table above show Adaptive Biotechnologies Corporation's gross profit by year and by quarter, including the growth rate.